{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T21:10:19Z","timestamp":1762981819535,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.diagmicrobio.2024.116215","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T11:34:53Z","timestamp":1707996893000},"page":"116215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Shorter versus longer duration of antimicrobial therapy for early Lyme disease: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4218-8493","authenticated-orcid":false,"given":"Maria Meritxell","family":"Roca Mora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa Marin","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Godoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Donadon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Clemente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia","family":"Marcolin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres","family":"Valenzuela S.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary P.","family":"Wormser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116215_bib0001","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.idc.2022.03.004","article-title":"Epidemiology of Lyme disease","volume":"36","author":"Mead","year":"2022","journal-title":"Infect Dis Clin N Am"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116215_bib0002","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM200107123450207","article-title":"Lyme disease","volume":"345","author":"Steere","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116215_bib0003","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/joim.13266","article-title":"Acrodermatitis chronica atrophicans: clinical and microbiological characteristics of a cohort of 693 Slovenian patients","volume":"290","author":"Ogrinc","year":"2021","journal-title":"J Intern Med"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2024.116215_bib0004","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116215_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciaa1215","article-title":"Clinical practice guidelines by the infectious diseases society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the prevention, diagnosis and treatment of Lyme disease","volume":"72","author":"Lantos","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2024.116215_bib0006","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1001\/jamadermatol.2018.3186","article-title":"Efficacy and safety of antibiotic therapy in early cutaneous Lyme borreliosis: a network meta-analysis","volume":"154","author":"Torbahn","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116215_bib0007","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00761-21","article-title":"Forty years of evidence on the efficacy and safety of oral and injectable antibiotics for treating Lyme disease of adults and children: a network meta-analysis","volume":"9","author":"Yang","year":"2021","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.diagmicrobio.2024.116215_bib0008","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3390\/pathogens10080972","article-title":"Methodological quality assessment with the AGREE II scale and a comparison of European and American guidelines for the treatment of Lyme borreliosis: a systematic review","volume":"10","author":"Nguala","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.diagmicrobio.2024.116215_bib0009","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.medmal.2019.05.001","article-title":"Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies (II). Biological diagnosis, treatment, persistent symptoms after documented or suspected Lyme borreliosis","volume":"49","author":"Jaulhac","year":"2019","journal-title":"Med Mal Infect"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116215_bib0010","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1473-3099(22)00528-X","article-title":"Treatment of erythema migrans with doxycycline for 7 days versus 14 days in Slovenia: a randomised open-label non-inferiority trial","volume":"23","author":"Stupica","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2024.116215_bib0011","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.diagmicrobio.2024.116215_bib0012","unstructured":"Higgins J.P.T., Thomas J., Chandler J., Cumpston M., Li T., Page M.J. et al. Cochrane handbook for systematic reviews of interventions version 6.4 (updated August 2023). Cochrane, 2023."},{"key":"10.1016\/j.diagmicrobio.2024.116215_bib0013","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116215_bib0014","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.diagmicrobio.2024.116215_bib0015","unstructured":"Deeks J., Higgins J. Statistical algorithms in review manager 5. Stat. Methods Group. Cochrane Collab. 2010, 1\u201311."},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116215_bib0016","doi-asserted-by":"crossref","first-page":"22","DOI":"10.7326\/0003-4819-99-1-22","article-title":"Treatment of the early manifestations of Lyme disease","volume":"99","author":"Steere","year":"1983","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2024.116215_bib0017","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-138-9-200305060-00005","article-title":"Duration of antibiotic therapy for early Lyme disease: a randomized, double-blind, placebo-controlled trial","volume":"138","author":"Wormser","year":"2003","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116215_bib0018","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000090657","article-title":"Comparison of a two- or three-week regimen and a review of treatment of erythema migrans with phenoxymethylpenicillin","volume":"212","author":"Aberer","year":"2006","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116215_bib0019","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1086\/649920","article-title":"Antibiotic treatment duration and long-term outcomes of patients with early Lyme disease from a Lyme disease-hyperendemic area","volume":"50","author":"Kowalski","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116215_bib0020","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/cid\/cis402","article-title":"Treatment of erythema migrans with doxycycline for 10 days versus 15 days","volume":"55","author":"Stupica","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"2 I","key":"10.1016\/j.diagmicrobio.2024.116215_bib0021","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0190-9622(95)90130-2","article-title":"Doxycycline versus tetracycline therapy for Lyme disease associated with erythema migrans","volume":"32","author":"Nowakowski","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.diagmicrobio.2024.116215_bib0022","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7326\/M19-1509","article-title":"Duration of antibiotic therapy: shorter is better","volume":"171","author":"Spellberg","year":"2019","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2024.116215_bib0023","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/cid\/ciw217","article-title":"executive summary: implementing an antibiotic stewardship program: guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116215_bib0024","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1473-3099(22)00581-3","article-title":"Erythema migrans: lyme disease does not need prolonged therapy","volume":"23","author":"Eldin","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2024.116215_bib0025","article-title":"Which trial do we need? Treatment of multiple erythema migrans with doxycycline for 7 days versus 14 days","author":"Stupica","year":"2023","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116215_bib0026","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/infdis\/jiaa719","article-title":"Genetic background amplifies the effect of immunodeficiency in antibiotic efficacy against Borrelia burgdorferi","volume":"224","author":"Sharma","year":"2021","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2024.116215_bib0027","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/infdis\/jiab520","article-title":"Response to determination of oral doxycycline efficacy for clearance of Borrelia burgdorferi infection","volume":"225","author":"Wormser","year":"2022","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2024.116215_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6506a1","article-title":"Core elements of outpatient antibiotic stewardship","volume":"65","author":"Sanchez","year":"2016","journal-title":"MMWR Recomm Rep"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889324000440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889324000440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:01:00Z","timestamp":1760004060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889324000440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0732889324000440"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116215","relation":{},"ISSN":["0732-8893"],"issn-type":[{"type":"print","value":"0732-8893"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shorter versus longer duration of antimicrobial therapy for early Lyme disease: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116215","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116215"}}